Loading...
Allogeneic hematopoietic stem cell transplantation versus hypomethylating agents in patients with myelodysplastic syndrome: A retrospective case–control study
Allogeneic stem cell transplantation (allo-SCT) is the only potentially curative treatment for myelodysplastic syndrome (MDS). Recently, hypomethylating agents (HMAs) have been shown to improve survival in patients with high-risk MDS. We conducted a retrospective case–control study to compare surviv...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4085133/ https://ncbi.nlm.nih.gov/pubmed/23345254 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23371 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|